Supporting the

Neuroendocrine Cancer Community

Pamela L. Kunz, MD, on Pancreatic Neuroendocrine Tumors

Pamela L. Kunz, MD, on Pancreatic Neuroendocrine Tumors

ASCO News on CapTem chemotherapy trial Associate Professor Pamela L. Kunz*, MD, of the Yale University School of Medicine, discusses new findings from the ECOG-ACRIN E2211 trial (ClinicalTrials.gov Identifier: NCT01824875): Temozolomide With or Without Capecitabine in...